SK Bioscience Co. Ltd

SK Bioscience Co. Ltd

World Rank (Jan-05-2024)
3,380
Market Cap (Jan-05-2024)
4.182 Billion USD
World Rank (Jul-30-2023)
3,335
Market Cap (Jul-30-2023)
4.352 Billion USD
World Rank (Jan-07-2022)
1,473
Market Cap (Jan-07-2022)
13.589 Billion USD
Headquarters Country
South Korea
CEO
Ahn Jae-yong
Employee Count
1,072
Employee Count as of Date
As on 2023
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
756 Million USD
Annual Net Income in USD
289 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
1,717 Million USD
Total Liabilities in USD
414 Million USD
Total Equity in USD
1,303 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Company Website
SK BIOSCIENCE CO.,LTD.
Company Profile

Biotechnology sector company with advanced vaccine R&D technology and productivity. Headquarters is in South Korea.

Founded Year
2018

Share